StockMarketWire.com - Credit Suisse today reaffirms its neutral investment rating on Mediclinic International Plc [LON:MDC] and cut its price target to 550p (from 660p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk